Waverly Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.03M Buy
164,689
+1,700
+1% +$92.3K 0.04% 360
2026
Q1
$10.2M Buy
162,989
+12,801
+9% +$1.02M 0.08% 250
2025
Q4
$14.3M Buy
150,188
+79,524
+113% +$7.8M 0.12% 164
2025
Q3
$6.9M Buy
70,664
+4,951
+8% +$513K 0.07% 266
2025
Q2
$7.06M Buy
65,713
+2,195
+3% +$222K 0.08% 239
2025
Q1
$6.41M Buy
63,518
+52,344
+468% +$5.27M 0.08% 240
2024
Q4
$998K Buy
11,174
+2,179
+24% +$192K 0.02% 508
2024
Q3
$754K Sell
8,995
-56
-0.6% -$4.41K 0.01% 498
2024
Q2
$697K Buy
9,051
+425
+5% +$31.1K 0.01% 503
2024
Q1
$591K Buy
8,626
+962
+13% +$61.9K 0.01% 448
2023
Q4
$443K Sell
7,664
-4
-0.1% -$214 0.02% 313
2023
Q3
$405K Buy
7,668
+18
+0.2% +$944 0.02% 284
2023
Q2
$414K Buy
+7,650
New +$400K 0.02% 262
2018
Q1
Sell
-14,412
Closed -$357K 206
2017
Q4
$357K Buy
14,412
+4,756
+49% +$131K 0.05% 178
2017
Q3
$282K Buy
+9,656
New +$267K 0.06% 184
2014
Q4
Sell
-310
Closed -$4K 457
2014
Q3
$4K Hold
310
﹤0.01% 652
2014
Q2
$4K Buy
310
+17
+6% +$221 ﹤0.01% 614
2014
Q1
$4K Sell
293
-146
-33% -$1.92K ﹤0.01% 579
2013
Q4
$5K Buy
+439
New +$5.19K ﹤0.01% 666

Other funds holding BSX

Waverly Advisors's BSX Position: Q2 2026 in Review

Waverly Advisors increased its Boston Scientific (BSX) stake by 1% in Q2 2026, buying an estimated $92.3K and bringing the position to 164,689 shares worth $7.03M. The position accounts for 0.04% of the portfolio, ranked #360.

Waverly Advisors first reported a position in BSX in Q4 2013 and has held it in 19 quarters since. The position peaked at $14.3M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Waverly Advisors held 164,689 shares of Boston Scientific worth $7.03M as of Q2 2026.
  • Waverly Advisors bought 1,700 Boston Scientific shares in Q2 2026, an estimated $92.3K.
  • Boston Scientific made up 0.04% of Waverly Advisors's portfolio in Q2 2026, its #360 holding.
  • Waverly Advisors first reported a position in Boston Scientific in Q4 2013 and has held it in 19 quarters since.
  • Waverly Advisors's Boston Scientific position peaked at $14.3M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.